Showing results (41-50 of 217) with videos related to
Sort By:
Pageof 22
Gynecologic Oncology|May 12, 2007
Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology groupGary L Eddy, Brian N Bundy, William T Creasman, et al.Gynecologic Oncology|August 11, 2007
A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group studyPeter G Rose, Koen Degeest, Scott McMeekin, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 4, 2016
Activity of Bevacizumab in Patients With Low-Grade Serous Ovarian CarcinomaPeter G Rose, Haider Mahdi, Amelia Jernigan, et al.American Journal of Obstetrics and Gynecology|November 6, 2007
Symptomatic vaginal bleeding in a postmenopausal woman: a case report of pancreatic adenocarcinoma metastasizing exclusively to the vaginaAmanda Nickles Fader, Jennifer A Brainard, Peter G RoseInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 16, 2015
Impact of Age on 30-Day Mortality and Morbidity in Patients Undergoing Surgery for Ovarian CancerHaider Mahdi, Andrew Wiechert, David Lockhart, et al.Journal of Gynecologic Oncology|May 26, 2017
Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactionsKathryn Maurer, Chad Michener, Haider Mahdi, et al.Anti-Cancer Drugs|May 2, 2026
Response of undifferentiated and dedifferentiated endometrial cancer to pembrolizumab: a case reportPeter G Rose, Johanna Kelley, Aaron Petty, et al.Gynecologic Oncology|October 11, 2005
Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology GroupGregory Sutton, Janice H Axelrod, Brian N Bundy, et al.Gynecologic Oncology|June 7, 2014
Racial disparity in the 30-day morbidity and mortality after surgery for endometrial cancerHaider Mahdi, David Lockhart, Mehdi Moslemi-Kebria, et al.Gynecologic Oncology|February 16, 2006
Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology GroupPeter G Rose, John A Blessing, Shashikant Lele, et al.Pageof 22